Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2ITHgA9
via IFTTT